M

MabVax Therapeutics, Inc.

4 employees

MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Pharmaceutical

Date founded

2006

Funding rounds raised

Total raised

$5.3M

from 4 investors over 4 rounds

M

MabVax Therapeutics, Inc. raised $1.8M on September 25, 2013

Investors: National Institutes of Health

M

MabVax Therapeutics, Inc. raised $5.3M on November 20, 2012

Investors: Numoda Capital and -

M

MabVax Therapeutics, Inc. raised undisclosed on January 2, 2012

Investors: BIOMARK CAPITAL

FAQ